Imatinib 400 mg cap: Supply issue and brand change
The supplier, AFT, has advised that its brand of imatinib mesilate cap 400 mg will go out of stock in December 2020.
The out of stock is caused by delays in production at the manufacturing plant.
To ensure continuity of supply, PHARMAC listed the Rex brand imatinib 400 mg cap from 1 December 2020. Pharmacode 2594323.
Originally, it was going to be listed in the Schedule on 1 January 2021.
We understand that stock will be available from mid-December. The sole supply and delisting dates remain unchanged. Imatinib-Rex will be sole supply from 1 June 2021.
The imatinib 100 mg cap is not affected by this stock issue. The Rex brand will be listed on 1 January 2021 as originally planned.
Both presentations of Imatinib-AFT will be delisted on 31 May 2020.